How has been the historical performance of Rossari Biotech?

Answer:The historical performance of Rossari Biotech shows a consistent growth trajectory in net sales and profitability over the years. Breakdown: Rossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025, reflecting a strong upward trend. The total operating income has followed a similar pattern, reaching INR 2,080.29 crore in March 2025, up from INR 600.09 crore in March 2020. The operating profit (PBDIT) has also improved, rising from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025, although the operating profit margin has slightly decreased from 17.45% in March 2020 to 12.74% in March 2025. Profit before tax has grown from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, and profit after tax has increased from INR 65.47 crore to INR 135.40 crore over the same period. The company's total assets have expanded from INR 471.46 crore in March 2020 to INR 1,885.67 crore in March 2025, while total liabilities have also risen from INR 471.46 crore to INR 1,885.67 crore. Cash flow from operating activities has shown improvement, increasing from INR 56 crore in March 2020 to INR 137 crore in March 2025, contributing to a net cash inflow of INR 19 crore in March 2025. Overall, Rossari Biotech has demonstrated robust growth in sales, profits, and asset accumulation over the past five years.